Target & Activity
| Target | Activity | Value |
|---|---|---|
| HIV-1 | EC50 | 1.4 μM |
| Eukaryotic topoisomerase I | 5 μM | |
| Aminopeptidase N | 7.3 μM |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| 4T1 | IC50 | 14.04 μM | Cytotoxicity against mouse 4T1 cells assessed as growth inhibition after 96 hrs by SRB assay | [PMID: 25817774] |
| 518A2 | IC50 | 0.33 μM | Antitumor activity against human 518A2 cells by SRB assay | [PMID: 31499360] |
| 518A2 | EC50 | 11.9 μM | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay | [PMID: 27142753] |
| 518A2 | IC50 | 11.9 μM | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay | [PMID: 24161703] |
| 518A2 | IC50 | 11.9 μM | Cytotoxicity against human 518A2 cells assessed as cell viability after 96 hrs by SRB assay | [PMID: 23245801] |
| 518A2 | IC50 | 11.9 μM | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay | [PMID: 20034802] |
| 518A2 | EC50 | 11.9 μM | Anticancer activity against human 518A2 cells measured after 96 hrs by sulforhodamine B assay | [PMID: 31330447] |
| 518A2 | EC50 | 11.9 μM | Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine B assay | [PMID: 26211461] |
| 518A2 | IC50 | 11.9 μM | Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine B assay | [PMID: 20846866] |
| 518A2 | IC50 | 11.9 μM | Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine B assay | [PMID: 20299226] |
| 518A2 | EC50 | 13.6 μM | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay | [PMID: 28169163] |
| 518A2 | IC50 | 14.8 μM | Cytotoxicity against human 518A2 cells assessed as cell viability after 96 hrs by SRB assay | [PMID: 23973824] |
| 518A2 | IC50 | 8.13 μM | Cytotoxicity against human 518A2 cells after 96 hrs by SRB colorimetric assay | [PMID: 20472329] |
| 518A2 | IC50 | 8.13 μM | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay | [PMID: 20451375] |
| 518A2 | EC50 | 9.4 μM | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay | [PMID: 28033541] |
| 518A2 | EC50 | 9.4 μM | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay | [PMID: 27017553] |
| 518A2 | EC50 | 9.4 μM | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay | [PMID: 26750249] |
| 518A2 | EC50 | 9.4 μM | Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay | [PMID: 26547057] |
| 518A2 | EC50 | 9.4 μM | Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine B assay | [PMID: 30278332] |
| 518A2 | EC50 | 9.4 μM | Cytotoxicity against human 518A2 cells assessed as reduction in cell proliferation after 96 hrs by sulforhodamine B assay | [PMID: 27149037] |
| 8505C | IC50 | 0.33 μM | Antitumor activity against human 8505C cells by SRB assay | [PMID: 31499360] |
21 records · Scroll to view more